Vaccination
Cosentyx® HS Secukinumab 300 mg - Reimbursement form prolongation (French)
Download French documentCosentyx® HS Secukinumab 300 mg - Reimbursement form prolongation (Dutch)
Download Dutch documentIndication
FABHALTA ® is indicated as monotherapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH) who have haemolytic anemia 1 .
FABHALTA® is the first and only Factor B inhibitor. FABHALTA® acts...
Twitter Linkedin Facebook Pinterest Google plusFabhalta®: RMP package - Dutch
The RMP material contains three documents HCP Brochure Patient/Caregiver brochure Patient Safety card To receive by post, click on the "Add to card" button below Find Fabhalta material on FAGG.be ....Fabhalta®: RMP package - French
The RMP material contains three documents HCP Brochure Patient/Caregiver brochure Patient Safety card To receive by post, click on the "Add to card" button below Find Fabhalta material on AFMPS.be ....Fabhalta®: Safety Card - French
Patient safety card To receive by post, click on the "Add to card" button below Find Fabhalta material on AFMPS.be .field-name-field-np4-expiry-date {display:none;}Fabhalta®: Safety Card - German
Patient safety card To receive by post, click on the "Add to card" button below .field-name-field-np4-expiry-date {display:none;}Fabhalta®: Patient and caregiver guide - Dutch
To receive by post, click on the "Add to card" button below Find Fabhalta material on FAGG.be .field-name-field-np4-expiry-date {display:none;}
